Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 May;73(10):1255–1259. doi: 10.1038/bjc.1996.240

Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor beta in breast cancer.

K D Amoils 1, L Seymour 1, W R Bezwoda 1
PMCID: PMC2074514  PMID: 8630288

Abstract

The utility of the polymerase chain reaction (PCR) as a technique for determining the expression of transforming growth factor beta (TGF-beta) and of the oestrogen receptor (ER) in clinical breast cancer tissue was examined. PCR analysis was compared with immunocytochemical assays for TGF-beta and for ER. Seventy confirmed breast carcinoma samples were analysed for ER using both techniques with a statistically highly significant concordance (P < 0.001) between the two methods. Nineteen samples were observed to be ER positive and 46 samples were found to be ER negative by both techniques. Forty-eight samples were analysed for TGF-beta using both PCR and immunocytochemistry. Of the 24 samples observed to be positive for TGF-beta by immunocytochemistry, all were found to be positive for TGF-beta mRNA (PCR). Similarly, the 24 samples observed to be TGF-beta negative by immunocytochemistry were also negative for TGF-beta mRNA, indicating 100% specificity and 100% sensitivity of the PCR technique. PCR is therefore considered a viable technique for analysis of both ER and TGF-beta in small samples such as fine-needle aspirates.

Full text

PDF
1255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Lee P., Travers M., Luqmani Y., Coombes R. C. Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer. 1990 Apr;61(4):612–617. doi: 10.1038/bjc.1990.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Clark G. M., Osborne C. K., McGuire W. L. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol. 1984 Oct;2(10):1102–1109. doi: 10.1200/JCO.1984.2.10.1102. [DOI] [PubMed] [Google Scholar]
  4. Cooke T., George D., Shields R., Maynard P., Griffiths K. Oestrogen receptors and prognosis in early breast cancer. Lancet. 1979 May 12;1(8124):995–997. doi: 10.1016/s0140-6736(79)92752-1. [DOI] [PubMed] [Google Scholar]
  5. Dao T. L., Nemoto T. Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast. Cancer. 1980 Dec 15;46(12 Suppl):2779–2782. doi: 10.1002/1097-0142(19801215)46:12+<2779::aid-cncr2820461407>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  6. DeSombre E. R., Carbone P. P., Jensen E. V., McGuire W. L., Wells S. A., Jr, Wittliff J. L., Lipsett M. B. Special report. Steriod receptors in breast cancer. N Engl J Med. 1979 Nov 1;301(18):1011–1012. doi: 10.1056/NEJM197911013011826. [DOI] [PubMed] [Google Scholar]
  7. DeSombre E. R., Thorpe S. M., Rose C., Blough R. R., Andersen K. W., Rasmussen B. B., King W. J. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res. 1986 Aug;46(8 Suppl):4256s–4264s. [PubMed] [Google Scholar]
  8. Fuqua S. A., Allred D. C., Elledge R. M., Krieg S. L., Benedix M. G., Nawaz Z., O'Malley B. W., Greene G. L., McGuire W. L. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res Treat. 1993;26(2):191–202. doi: 10.1007/BF00689692. [DOI] [PubMed] [Google Scholar]
  9. Glauber J. G., Kiang D. T. The changing role of hormonal therapy in advanced breast cancer. Semin Oncol. 1992 Jun;19(3):308–316. [PubMed] [Google Scholar]
  10. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  11. Hirayama D., Fujimori T., Satonaka K., Nakamura T., Kitazawa S., Horio M., Maeda S., Nagasako K. Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer. Hum Pathol. 1992 Jun;23(6):681–685. doi: 10.1016/0046-8177(92)90325-w. [DOI] [PubMed] [Google Scholar]
  12. Jonat W., Maass H., Stegner H. E. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res. 1986 Aug;46(8 Suppl):4296s–4298s. [PubMed] [Google Scholar]
  13. King W. J., DeSombre E. R., Jensen E. V., Greene G. L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985 Jan;45(1):293–304. [PubMed] [Google Scholar]
  14. Knabbe C., Lippman M. E., Wakefield L. M., Flanders K. C., Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987 Feb 13;48(3):417–428. doi: 10.1016/0092-8674(87)90193-0. [DOI] [PubMed] [Google Scholar]
  15. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  16. Korenman S. G., Dukes B. A. Specific estrogen binding by the cytoplasm fof human breast carcinoma. J Clin Endocrinol Metab. 1970 May;30(5):639–645. doi: 10.1210/jcem-30-5-639. [DOI] [PubMed] [Google Scholar]
  17. Lippman M. E., Allegra J. C. Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer. 1980 Dec 15;46(12 Suppl):2829–2834. doi: 10.1002/1097-0142(19801215)46:12+<2829::aid-cncr2820461419>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  18. Maynard P. V., Blamey R. W., Elston C. W., Haybittle J. L., Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed] [Google Scholar]
  19. McCarty K. S., Jr, Szabo E., Flowers J. L., Cox E. B., Leight G. S., Miller L., Konrath J., Soper J. T., Budwit D. A., Creasman W. T. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 1986 Aug;46(8 Suppl):4244s–4248s. [PubMed] [Google Scholar]
  20. Osborne C. K., Yochmowitz M. G., Knight W. A., 3rd, McGuire W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980 Dec 15;46(12 Suppl):2884–2888. doi: 10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  21. Paridaens R., Sylvester R. J., Ferrazzi E., Legros N., Leclercq G., Heuson J. C. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer. 1980 Dec 15;46(12 Suppl):2889–2895. doi: 10.1002/1097-0142(19801215)46:12+<2889::aid-cncr2820461430>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  22. Pegoraro R. J., Karnan V., Nirmul D., Joubert S. M. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res. 1986 Apr;46(4 Pt 2):2117–2120. [PubMed] [Google Scholar]
  23. Pelton R. W., Dickinson M. E., Moses H. L., Hogan B. L. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development. 1990 Oct;110(2):609–620. doi: 10.1242/dev.110.2.609. [DOI] [PubMed] [Google Scholar]
  24. Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J. 1988 Nov;7(11):3385–3388. doi: 10.1002/j.1460-2075.1988.tb03211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roberts A. B., Thompson N. L., Heine U., Flanders C., Sporn M. B. Transforming growth factor-beta: possible roles in carcinogenesis. Br J Cancer. 1988 Jun;57(6):594–600. doi: 10.1038/bjc.1988.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stefanini M., De Martino C., Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature. 1967 Oct 14;216(5111):173–174. doi: 10.1038/216173a0. [DOI] [PubMed] [Google Scholar]
  27. Thorpe S. M., Rose C., Rasmussen B. B., Mouridsen H. T., Bayer T., Keiding N. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res. 1987 Nov 15;47(22):6126–6133. [PubMed] [Google Scholar]
  28. Wittliff J. L. Steroid-hormone receptors in breast cancer. Cancer. 1984 Feb 1;53(3 Suppl):630–643. doi: 10.1002/1097-0142(19840201)53:3+<630::aid-cncr2820531308>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES